Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2025 19:43 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO

RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026
December 05, 2025 07:26 ET | Source: Research and Markets

U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
November 25, 2025 11:22 ET | Source: Research and Markets

Dry (Atrophic) Macular Degeneration Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The...
November 04, 2025 09:00 ET | Source: Optigo Biotherapeutics Inc.

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

Dr. Andreas Wallnöfer joins the board of Optigo Biotherapeutics – the ophthalmology company pioneering next-gen treatments for retinal diseases.
October 20, 2025 16:35 ET | Source: Bio Usawa Inc

Bio Usawa Announces Approval of BioUcenta™ by the Rwandan FDA

KIGALI, Rwanda and SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The Rwanda Food and Drugs Authority has granted market approval for Bio Usawa Biotechnology Ltd.’s (Bio Usawa) BioUcenta™, a...
October 01, 2025 06:01 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

RetinalGenix Technologies and RGEN Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases.
September 25, 2025 06:15 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
September 12, 2025 06:44 ET | Source: Research and Markets

North America Vision Care Market Report 2025-2033 | EssilorLuxottica, Johnson & Johnson Vision, CooperVision, Bausch + Lomb, and Alcon Lead the 37.7 Bn Competitive Landscape

Dublin, Sept. 12, 2025 (GLOBE NEWSWIRE) -- The "North America Vision Care Market Size, Share, Trends and Forecast by Product Type, Distribution Channel, and Country, 2025-2033" report has been added...
August 05, 2025 08:51 ET | Source: Research and Markets

Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon

Dublin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Vision Care Market Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering.Saudi Arabia Vision Care Market is...
July 28, 2025 07:21 ET | Source: Research and Markets

AAV for the Hereditary Retinal Diseases Market Competitive Landscape Report 2025 | Novartis, MeiraGTx, 4D Molecular Therapeutics, and Beacon Therapeutics Lead the Charge in Innovative Therapies

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "AAV for the Hereditary Retinal Diseases - Competitive Landscape, 2025" has been added to ResearchAndMarkets.com's offering. "AAV for the Hereditary...